It provides automatic Part D coverage for FDA-approved weight loss medications (Wegovy, Zepbound, and Foundayo) at a $50 monthly copay, regardless of whether you have a secondary qualifying indication
Your Best Shot: The Personalized System for Optimal Weight HealthGLP-1 Shot or Not [Koff RD, Ashley] on Amazon.com
A Peptide Debate is Rocking Ultra-Running
More telling than the raw number is the breakdown by category
BPC 157 is also known to help irritable bowel syndrome and gastric ulcers, subjects with stomach issues seem to prefer the capsule form as it goes straight to the problem area
Brown E, Heerspink H, Cuthbertson DJ, et al